Major depressive disorder with anxious features - the role of pregabalin

被引：0
|
作者：
Carvalho, R. S. [1 ]
Afonso, B. R. [1 ]
Santos, E. [1 ]
机构：
[1] Hosp Magalhaes Lemos, Psiquiatria, Porto, Portugal
来源：
EUROPEAN PSYCHIATRY | 2023年 / 66卷
关键词：
D O I：
10.1192/j.eurpsy.2023.1785
中图分类号：
R749 [精神病学];
学科分类号：
100205 ;
摘要：
EPV0451
引用
收藏
页码：S843 / S843
页数：1
相关论文
共 50 条
  • [1] Major depressive disorder with anxious features - the role of pregabalin
    Carvalho, R. S.
    Afonso, B. R.
    Santos, E.
    [J]. EUROPEAN PSYCHIATRY, 2023, 66 : S843 - S843
  • [2] The role of anxious distress in immune dysregulation in patients with major depressive disorder
    Roxanne Gaspersz
    Femke Lamers
    Gayle Wittenberg
    Aartjan T. F. Beekman
    Albert M. van Hemert
    Robert A. Schoevers
    Brenda W. J. H. Penninx
    [J]. Translational Psychiatry, 7
  • [3] The role of anxious distress in immune dysregulation in patients with major depressive disorder
    Gaspersz, Roxanne
    Lamers, Femke
    Wittenberg, Gayle
    Beekman, Aartjan T. F.
    van Hemert, Albert M.
    Schoevers, Robert A.
    Penninx, Brenda W. J. H.
    [J]. TRANSLATIONAL PSYCHIATRY, 2017, 7
  • [4] Lumateperone in the Treatment of Patients With Major Depressive Disorder and Bipolar Disorder With Anxious Distress and Mixed Features
    Durgam, Suresh
    Kozauer, Susan G.
    Earley, Willie R.
    Huo, Jason
    Mates, Sharon
    Sachs, Gary S.
    [J]. NEUROPSYCHOPHARMACOLOGY, 2023, 48 : 199 - 200
  • [5] Pregabalin augmentation to antidepressants in patients with major depressive disorder
    Pae, Chi-Un
    [J]. PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY, 2009, 33 (03): : 577 - 578
  • [6] Adjunctive Aripiprazole in Major Depressive Disorder: Analysis of Efficacy and Safety in Patients With Anxious and Atypical Features
    Trivedi, Madhukar H.
    Thase, Michael E.
    Fava, Maurizio
    Nelson, J. Craig
    Yang, Huyuan
    Qi, Ying
    Tran, Quynh-Van
    Pikalov, Andrei
    Carlson, Berit X.
    Marcus, Ronald N.
    Berman, Robert M.
    [J]. JOURNAL OF CLINICAL PSYCHIATRY, 2008, 69 (12) : 1928 - 1936
  • [7] Adjunctive pregabalin in patients with major depressive disorder and enduring anxiety
    Hrnjica, A.
    Bise, S.
    Setic, R.
    Lokmic-Pekic, I.
    Sulejmanpasic, G.
    [J]. EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2019, 29 : S528 - S529
  • [8] The Potential Role of Aripiprazole Augmentation for Major Depressive Disorder with Anxious Distress in Naturalistic Treatment Setting
    Lee, Seung-Hoon
    Lee, Kyung Ho
    Han, Tae Sun
    Han, Changsu
    Bahk, Won-Myong
    Lee, Soo-Jung
    Patkar, Ashwin A.
    Masand, Prakash S.
    Pae, Chi-Un
    [J]. CLINICAL PSYCHOPHARMACOLOGY AND NEUROSCIENCE, 2024, 22 (02) : 370 - 375
  • [9] Adjunctive Pregabalin in Partial Responders With Major Depressive Disorder and Residual Anxiety
    Vitali, Mario
    Tedeschini, Enrico
    Mistretta, Martino
    Fehling, Kiki
    Aceti, Franca
    Ceccanti, Mauro
    Fava, Maurizio
    [J]. JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY, 2013, 33 (01) : 95 - 98
  • [10] What clinical and symptom features and comorbid disorders characterize outpatients with anxious major depressive disorder: A replication and extension
    Fava, Maurizio
    Rush, A. John
    Alpert, Jonathan E.
    Carmin, Cheryl N.
    Balasubramani, G. K.
    Wisniewski, Stephen R.
    Trivedi, Madhukar H.
    Biggs, Melanie M.
    Shores-Wilson, Kathy
    [J]. CANADIAN JOURNAL OF PSYCHIATRY-REVUE CANADIENNE DE PSYCHIATRIE, 2006, 51 (13): : 823 - 835
12345